Daxor
Daxor

DXR - Daxor • Dividends

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding DateValue (U$)Frequency
1/5/2018
0,03
Biannual
12/20/2017
0,03
Biannual
12/20/2016
0,03
Biannual
12/18/2015
0,04
Biannual
12/4/2014
0,03
Biannual
12/5/2013
0,05
Biannual
12/7/2012
0,1
Biannual
8/10/2012
0,1
Biannual
11/16/2011
0,1
Biannual
5/27/2011
0,15
Biannual
12/14/2010
0,65
Biannual
9/13/2010
0,25
Biannual
5/27/2010
0,1
Biannual
12/8/2009
1
Biannual
8/21/2009
0,25
Biannual
5/27/2009
0,1
Biannual
1/2

The latest dividend from DXR was $0.03 per share (ex-dividend 1/5/2018). The dividend yield over the last 12 months is 0%.